BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35102178)

  • 41. An acyclic phosphonate prodrug of HPMPC is effective against VZV in skin organ culture and mice.
    Lloyd MG; Liu D; Lyu J; Fan J; Overhulse JM; Kashemirov BA; Prichard MN; McKenna CE; Moffat JF
    Antiviral Res; 2022 Mar; 199():105275. PubMed ID: 35248614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus.
    Baszczyňski O; Kaiser MM; Česnek M; Břehová P; Jansa P; Procházková E; Dračínský M; Snoeck R; Andrei G; Janeba Z
    Antivir Chem Chemother; 2018; 26():2040206618813050. PubMed ID: 30497281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation.
    Schmutzhard J; Merete Riedel H; Zweygberg Wirgart B; Grillner L
    J Clin Virol; 2004 Feb; 29(2):120-6. PubMed ID: 14747031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.
    Rowe J; Greenblatt RJ; Liu D; Moffat JF
    Antiviral Res; 2010 Jun; 86(3):276-85. PubMed ID: 20307580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of a thiourea derivative that targets viral transactivators of cytomegalovirus and herpes simplex virus type 1.
    Kondo H; Koshizuka T; Majima R; Takahashi K; Ishioka K; Suzutani T; Inoue N
    Antiviral Res; 2021 Dec; 196():105207. PubMed ID: 34774602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fattiviracin A1, a novel antiviral agent produced by Streptomyces microflavus strain No. 2445. II. Biological properties.
    Yokomizo K; Miyamoto Y; Nagao K; Kumagae E; Habib ES; Suzuki K; Harada S; Uyeda M
    J Antibiot (Tokyo); 1998 Nov; 51(11):1035-9. PubMed ID: 9918397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
    Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Molecular Tweezer CLR01 Inhibits Antibody-Resistant Cell-to-Cell Spread of Human Cytomegalovirus.
    Brenner S; Braun B; Read C; Weil T; Walther P; Schrader T; Münch J; von Einem J
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Herpesviridae and novel inhibitors.
    Siakallis G; Spandidos DA; Sourvinos G
    Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
    Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell Culture Evolution of a Herpes Simplex Virus 1 (HSV-1)/Varicella-Zoster Virus (VZV) UL34/ORF24 Chimeric Virus Reveals Novel Functions for HSV Genes in Capsid Nuclear Egress.
    Roller RJ; Hassman T; Haugo-Crooks A
    J Virol; 2021 Nov; 95(23):e0095721. PubMed ID: 34523964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo.
    Bernstein DI; Goyette N; Cardin R; Kern ER; Boivin G; Ireland J; Juteau JM; Vaillant A
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2727-33. PubMed ID: 18505857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses.
    Prichard MN; Williams JD; Komazin-Meredith G; Khan AR; Price NB; Jefferson GM; Harden EA; Hartline CB; Peet NP; Bowlin TL
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3518-27. PubMed ID: 23669381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
    Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.
    Kim HT; Kim DK; Kim YW; Kim KH; Sugiyama Y; Kikuchi M
    Antiviral Res; 1995 Nov; 28(3):243-51. PubMed ID: 8629816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.
    Piret J; Lamontagne J; Bestman-Smith J; Roy S; Gourde P; Désormeaux A; Omar RF; Juhász J; Bergeron MG
    J Clin Microbiol; 2000 Jan; 38(1):110-9. PubMed ID: 10618073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
    Martin-Gandul C; Stampf S; Héquet D; Mueller NJ; Cusini A; van Delden C; Khanna N; Boggian K; Hirzel C; Soccal P; Hirsch HH; Pascual M; Meylan P; Manuel O;
    Am J Transplant; 2017 Jul; 17(7):1813-1822. PubMed ID: 28039960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.